BPH -- which stands for benign prostatic hyperplasia or hypertrophy -- is an enlargement of the prostate gland that occurs with aging. The prostate goes through two growth periods as a man ages. The first growth cycle occurs in puberty when the prostate doubles in size. The second growth cycle begins at around age 25 and generally continues throughout a man's life.
As it enlarges, the prostate can squeeze the urethra and disrupt the flow of urine from the bladder, resulting in symptoms that may include:
UroLift is an FDA-approved treatment method for BPH that uses tiny implants to hold the enlarged prostate tissue away from the urethra, the small tube that carries urine from the bladder. This prevents the prostate tissue from disrupting the flow of urine, which relieves your urinary symptoms. The minimally-invasive procedure requires no removal of prostate tissue, making it the first and only BPH treatment that does not negatively impact sexual function.
UroLift is an outpatient procedure that doesn’t require a hospital stay. Your provider may choose to use local anesthesia that numbs the area or general anesthesia that keeps you asleep during the procedure. Your provider passes the UroLift delivery device through the urethra and deploys the tiny implants that hold back the prostate tissue. Most patients require four implants.
Most patients don’t require a postoperative catheter and can generally be released home soon after the procedure. Your doctor will advise you when to resume normal activities, but recovery time is typically minimal. Symptom relief can occur immediately after the procedure but full results may take a few weeks.
There are alternative treatment options available for BPH, including medication and surgery. UroLift is an effective treatment for many patients wishing to preserve sexual function and avoid surgery or the side effects associated with medications. One of our urologists can recommend the most effective treatment option for your circumstance.